LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 6.21 | 21.74 | 717 | 392 | 1.8291 | 1.3114 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 6.21 | 21.74 | 1 | 392 | 0.0026 | -0.5219 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 6.21 | 21.74 | 921 | 392 | 2.3495 | 1.4544 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 8.19 | 21.74 | 1 | 439 | 0.0023 | -0.5082 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 8.19 | 21.74 | 819 | 439 | 1.8620 | 1.3081 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 8.19 | 21.74 | 5 | 439 | 0.0114 | -0.2873 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 8.19 | 21.74 | 1029 | 439 | 2.3394 | 1.4328 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 10.16 | 21.74 | 1 | 463 | 0.0022 | -0.5022 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 10.16 | 21.74 | 877 | 463 | 1.8915 | 1.3107 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 10.16 | 21.74 | 9 | 463 | 0.0194 | -0.1811 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 10.16 | 21.74 | 1088 | 463 | 2.3466 | 1.4263 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.13 | 21.74 | 1 | 496 | 0.0020 | -0.4945 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.13 | 21.74 | 932 | 496 | 1.8777 | 1.2996 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.13 | 21.74 | 7 | 496 | 0.0141 | -0.2221 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 12.13 | 21.74 | 1137 | 496 | 2.2907 | 1.4032 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 14.10 | 21.74 | 5 | 540 | 0.0092 | -0.2716 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 14.10 | 21.74 | 963 | 540 | 1.7803 | 1.2649 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 14.10 | 21.74 | 6 | 540 | 0.0111 | -0.2424 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 14.10 | 21.74 | 1192 | 540 | 2.2036 | 1.3715 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.07 | 21.74 | 6 | 597 | 0.0100 | -0.2360 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.07 | 21.74 | 1062 | 597 | 1.7763 | 1.2554 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.07 | 21.74 | 1 | 597 | 0.0017 | -0.4748 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 16.07 | 21.74 | 1299 | 597 | 2.1728 | 1.3524 | MN20160310_N01 | K18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.04 | 21.74 | 160 | 750 | 0.2132 | 0.4779 | MN20160310_N01 | D09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 18.04 | 21.74 | 1177 | 750 | 1.5681 | 1.1841 | MN20160310_N01 | D09 |